Moreover, serum FGF-2 levels are increased during progression of chronic liver disease and correlate with large tumors (>5 cm), with the presence of venous invasion and with advanced TNM stage, suggesting a role for FGF-2 in HCC angiogenesis progression [69,70]. Here, FGF2 is linked to hepatocellular carcinoma.